Parker MJ, Khan RJK, Crawford J, Pryor GA. Hemiarthroplasty versus internal fixation for displaced intracapsular hip fractures in the elderly. The Journal of Bone and Joint Surgery British volume. 2002;84-B(8):1150–5.
2.
Laursen JO. Treatment of intracapsular fractures of the femoral neck in Denmark: Trends in indications over the past decade. Acta Orthop Belg. 1999;65(4):478–84.
3.
Iorio R, Schwartz B, Macaulay W, Teeney SM, Healy WL, York S. Surgical Treatment of Displaced Femoral Neck Fractures in the Elderly. The Journal of Arthroplasty. 2006;21(8):1124–33.
4.
Crossman PT, Khan RJK, MacDowell A, Gardner AC, Reddy NS, Keene GS. A survey of the treatment of displaced intracapsular femoral neck fractures in the UK. Injury. 2002;33(5):383–6.
5.
Bhandari M, Devereaux PJ, Tornetta P, Swiontkowski MF, Berry DJ, Haidukewych G, et al. Operative Management of Displaced Femoral Neck Fractures in Elderly Patients. The Journal of Bone & Joint Surgery. 2005;87(9):2122–30.
6.
HARRIS WH. Traumatic Arthritis of the Hip after Dislocation and Acetabular Fractures. The Journal of Bone & Joint Surgery. 1969;51(4):737–55.
7.
Freyd M. The Graphic Rating Scale. Journal of Educational Psychology. 14(2):83–102.
8.
III, MD.
9.
Parker MJ, Raghavan R, Gurusamy K. Incidence of Fracture-healing Complications after Femoral Neck Fractures. Clinical Orthopaedics & Related Research. 2007;458:175–9.
10.
Nauth A, Miclau T, Bhandari M, Schemitsch EH. Use of Osteobiologics in the Management of Osteoporotic Fractures. Journal of Orthopaedic Trauma. 2011;25(Supplement 2):S51–5.
11.
Interventional procedure overview of autologous blood injection for tendinopathy. NICE interventionnal procedures guidance. 2008;
12.
Ren W, Wang F, Sun L. Role of autologous platelet-rich plasma in the treatment of femoral neck fractures.
13.
Redler LH, Thompson SA, Hsu SH, Ahmad CS, Levine WN. Platelet-Rich Plasma Therapy: A Systematic Literature Review and Evidence for Clinical Use. The Physician and Sportsmedicine. 2011;39(1):42–51.
14.
Intini G. The use of platelet-rich plasma in bone reconstruction therapy. Biomaterials. 2009;30(28):4956–66.
15.
Alsousou J, Thompson M, Hulley P, Noble A, Willett K. The biology of platelet-rich plasma and its application in trauma and orthopaedic surgery. The Journal of Bone and Joint Surgery British volume. 2009;91-B(8):987–96.
16.
Hall MP, Band PA, Meislin RJ, Jazrawi LM, Cardone DA. Platelet-rich Plasma: Current Concepts and Application in Sports Medicine. Journal of the American Academy of Orthopaedic Surgeons. 2009;17(10):602–8.
17.
Lu-Yao GL, Keller RB, Littenberg B, Wennberg JE. Outcomes after displaced fractures of the femoral neck. A meta-analysis of one hundred and six published reports. The Journal of Bone & Joint Surgery. 1994;76(1):15–25.
18.
Dennison E, Mohamed MA, Cooper C. Epidemiology of Osteoporosis. Rheumatic Disease Clinics of North America. 2006;32(4):617–29.
19.
Singer BR, McLauchlan GJ, Robinson CM, Christie J. Epidemiology of fractures in 15 000 adults. The Journal of Bone and Joint Surgery British volume. 1998;80-B(2):243–8.
20.
Griffin XL, Achten J, Parsons N, Costa ML. Platelet-rich therapy in the treatment of patients with hip fractures: a single centre, parallel group, participant-blinded, randomised controlled trial. BMJ Open. 2013;3(6):e002583.
21.
Samy AM. The role of platelet rich plasma in management of fracture neck femur: new insights. International Orthopaedics. 2016;40(5):1019–24.
The statements, opinions and data contained in the journal are solely those of the individual authors and contributors and not of the publisher and the editor(s). We stay neutral with regard to jurisdictional claims in published maps and institutional affiliations.
